Release Date: February 12, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Carlos, you mentioned plans for disciplined reinvestment this year, expecting gross margin expansion and flat pricing in 2025. What gives you confidence that this plan provides adequate investment to get key brands back into volume growth? A: Carlos Abrams-Rivera, CEO: We increased our margin by 100 bps in 2024 and expect a modest expansion in 2025. Our growth pillars are already in motion, with 75% of new customer wins locked in for Away From Home and a 17% distribution increase in Emerging Markets. In North America Retail, 75% of the 2025 innovation pipeline is secured. We're investing in price, product, and marketing, leveraging technology-led solutions for efficiency, and shifting more marketing dollars towards consumer-facing efforts.
Q: How are you thinking about the growth rates for each of the pillars within the organic sales guidance for 2025? A: Andre Maciel, CFO: Emerging Markets will see gradual improvements, exiting at double-digit growth. Away From Home will improve slightly in Q1 and build throughout the year, exiting around mid-single-digit growth. In the US, most improvement will come from the Accelerate platforms, where we're investing in price and product enhancements.
Q: Are you seeing any impact from GLP-1 injectable weight-loss drugs, and what opportunities are there to meet the needs of these patients? A: Carlos Abrams-Rivera, CEO: We haven't seen a meaningful impact from GLP-1. Consumers using these drugs often seek more protein and hydration options. We're highlighting protein content in products like Oscar Mayer, Lunchables, and Heinz beans, and ensuring our portfolio offers taste elevation for any protein consumers use.
Q: Can you provide an update on the Lunchables business recovery, considering the supplier issue in Q4? A: Carlos Abrams-Rivera, CEO: The supplier issue will improve significantly by the end of Q1. We're investing in the business with better quality, ingredients, and innovation. Despite current softness, we expect improvements as we resolve these issues and enhance the product.
Q: What is driving the increase in your tax rate for 2025, and how does it compare to other companies? A: Andre Maciel, CFO: We recorded a $2.4 billion tax benefit in Q4 linked to a business operation transfer, reducing cash impact from global minimum tax regulations. This results in a 500 bps increase in the P&L tax rate for 2025, but only a 200-300 bps increase in the cash tax rate, which is our primary focus.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.